With the Hospital Anxiety and Depression Scale , 11/19 ( 58 % ) patients with methylphenidate and 10/24 ( 42 % ) with placebo improved from a score compatible with depression in the first 7 days ( difference 16 % ; 95 % CI 13 % to 42 % ; p = 0.29 ) .